Inventor
SIEGMUND AARON C
US23 patents
⚠️ This page may combine multiple inventors who share the name “SIEGMUND AARON C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
16 patentsUS11096939B2Aug 24, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC24 citations94
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US9066954B2Jun 30, 2015
Fused heterocyclic derivatives and methods of use
AMGEN INC22 citations91
US7652009B2Jan 26, 2010
Substituted heterocycles and methods of use
AMGEN INC33 citations91
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US11807693B2Nov 7, 2023
Apelin polypeptides
AMGEN INC0 citations62
US10941182B2Mar 9, 2021
Apelin polypeptides
AMGEN INC0 citations61
US7429594B2Sep 30, 2008
Substituted heterocyclic compounds and methods of use
AMGEN INC4 citations58
US11548903B2Jan 10, 2023
Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
AMGEN INC0 citations52
US11021493B2Jun 1, 2021
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
AMGEN INC0 citations52
US9550762B2Jan 24, 2017
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC1 citations51
US12473289B2Nov 18, 2025
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
AMGEN INC0 citations46
US10246429B2Apr 2, 2019
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC0 citations41